EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review

Alvin Man Lung Chan iD, Jin Min Cheah, Yogeswaran Lokanathan iD, Min Hwei Ng, Jia Xian Law iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24044026 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alvin Man Lung Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia. Hauptthemen laut MEDLINE: Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ming Medical Sdn Bhd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is the second leading contributor to global deaths caused by non-communicable diseases. The cancer cells are known to interact with the surrounding non-cancerous cells, including the immune cells and stromal cells, within the tumor microenvironment (TME) to modulate the tumor progression, metastasis and resistance. Currently, chemotherapy and radiotherapy are the standard treatments for cancers. However, these treatments cause a significant number of side effects, as they damage both the cancer cells and the actively dividing normal cells indiscriminately. Hence, a new generation of immunotherapy using natural killer (NK) cells, cytotoxic CD8+ T-lymphocytes or macrophages was developed to achieve tumor-specific targeting and circumvent the adverse effects. However, the progression of cell-based immunotherapy is hindered by the combined action of TME and TD-EVs, which render the cancer cells less immunogenic. Recently, there has been an increase in interest in using immune cell derivatives to treat cancers. One of the highly potential immune cell derivatives is the NK cell-derived EVs (NK-EVs). As an acellular product, NK-EVs are resistant to the influence of TME and TD-EVs, and can be designed for “off-the-shelf” use. In this systematic review, we examine the safety and efficacy of NK-EVs to treat various cancers in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsExtracellular VesiclesHumansKiller Cells, NaturalT-LymphocytesImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

cancerexosomesextracellular vesiclesimmunotherapynatural killer cells

Autor:innen und Institutionen

  • Centre for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
  • Ming Medical Sdn Bhd, D3-3 (2nd Floor), Block D3 Dana 1 Commercial Centre, Jalan PJU 1a/22, Petaling Jaya 47101, Malaysia.

ORCID-Profile: Alvin Man Lung Chan, Yogeswaran Lokanathan, Jia Xian Law

Förderung

  • Ming Medical Sdn Bhd

Zitieren

APA

Chan, A. M. L., Cheah, J. M., Lokanathan, Y., Ng, M. H., & Law, J. X. (2023). Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044026

Vancouver

Chan AML, Cheah JM, Lokanathan Y, Ng MH, Law JX. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044026

BibTeX
@article{Chan2023,
  author = {Chan, Alvin Man Lung and Cheah, Jin Min and Lokanathan, Yogeswaran and Ng, Min Hwei and Law, Jia Xian},
  title = {Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24044026}
}
Kostenlos starten →